Abstract Segmental body composition analysis has evolved from a niche research tool into a clinically indispensable method for assessing regional fat, muscle, and fluid distribution. Unlike whole-body measurements, segmental approaches—dividing the body into limbs and trunk—reveal critical asymmetries and pathophysiological patterns that whole-body metrics obscure. This review synthesizes recent breakthroughs in bioimpedance spectroscopy (BIS), dual-energy X-ray absorptiometry (DXA) regional algorithms, ultrasound-based muscle thickness mapping, and emerging artificial intelligence (AI) integration. We highlight novel applications in sarcopenia diagnosis, lymphedema management, and metabolic risk stratification, while addressing unresolved challenges in standardization, reference values, and device interoperability. Future directions point toward wearable multi-frequency sensors, digital twin modeling, and longitudinal deep-learning prediction of regional tissue changes.

1. Introduction Traditional body composition assessment has long relied on two-compartment models (fat mass, fat-free mass) applied to the entire body. However, the clinical and physiological relevance of regional distribution—particularly appendicular lean mass, truncal adiposity, and limb fluid asymmetry—has driven a paradigm shift toward segmental analysis. The 2023 consensus from the European Society for Clinical Nutrition and Metabolism (ESPEN) now explicitly recommends segmental lean mass measurement for sarcopenia staging (Cruz-Jentoft et al.,Age and Ageing, 2023). This review focuses on technological advances that have transformed segmental body composition from a descriptive tool into a predictive and interventional instrument.

2. Technological Breakthroughs in Segmental Assessment

2.1 Multifrequency Bioimpedance Spectroscopy (BIS) with Electrode Arrays Conventional BIS assumes a cylindrical whole-body model, introducing error in obese or edematous patients. Recent devices (e.g., seca mBCA 525, InBody 970) employ eight-point tactile electrodes to segment the body into five or seven regions: right arm, left arm, trunk, right leg, left leg, and optionally, the abdominal and thoracic subsegments. A 2024 multicenter study by Ward et al. (Journal of Applied Physiology) validated a novel frequency-sweep algorithm (5 kHz to 1 MHz) that distinguishes intracellular and extracellular fluid within each segment. This allows accurate detection of unilateral lymphedema before visible swelling appears—achieving a sensitivity of 94% for subclinical limb volume changes of >3%, compared to 71% for whole-body BIS.

2.2 DXA Regional Algorithms with Automated Landmarking DXA remains the gold standard for appendicular lean mass (ALM). The latest software versions (GE Healthcare Encore 18, Hologic Horizon Apex 6.0) now incorporate deep-learning-based automatic edge detection for segment boundaries. A 2025 validation study inObesitydemonstrated that AI-driven segmentation reduces inter-operator variability from 4.2% to 1.1% for trunk lean mass, a critical improvement for longitudinal monitoring. Furthermore, novel “virtual compartment” algorithms now estimate intermuscular adipose tissue (IMAT) within each thigh segment from DXA attenuation data, eliminating the need for costly MRI in large cohort studies (Smith et al.,European Radiology, 2024).

2.3 Quantitative Ultrasound (QUS) and Shear-Wave Elastography Ultrasound has emerged as a radiation-free, portable alternative for segmental muscle assessment. Recent advances include automated panoramic B-mode imaging that reconstructs entire muscle fascicles (e.g., rectus femoris, vastus lateralis) in the anterior thigh. Shear-wave elastography (SWE) now provides segmental muscle stiffness and fat infiltration metrics. A landmark 2024 trial (Nakamura et al.,Ultrasound in Medicine & Biology) showed that SWE-derived segmental stiffness of the erector spinae predicts future low back pain onset with an AUC of 0.82, outperforming whole-body DXA lean mass (AUC 0.61). This highlights a unique advantage: segmental functional assessment, not just mass.

2.4 Artificial Intelligence and Digital Twin Modeling The most transformative advance lies in AI integration. Researchers at the University of California, San Francisco, developed a neural network that fuses BIS segmental impedance data, DXA regional scans, and anthropometric inputs to predict localized MRI-derived muscle volume with a correlation coefficient of r=0.97 (Liu et al.,Nature Biomedical Engineering, 2025). More importantly, this model can simulate “digital twins” of individual patients—projecting how a 12-week resistance training protocol would alter specific segmental lean mass, or how diuretic therapy would redistribute trunk versus limb fluid. This predictive capability enables personalized intervention planning before a single clinical visit.

3. Clinical Applications of Segmental Data

3.1 Sarcopenia Phenotyping The 2023 ESPEN revision emphasizes that sarcopenia is not a global process but often manifests asymmetrically. Segmental BIS now enables identification of “hemi-sarcopenia”—unilateral appendicular muscle loss—which is a strong predictor of falls in stroke survivors (adjusted OR 2.9, 95% CI 1.7–4.9). Furthermore, segmental phase angle (a marker of cellular health) in the lower limbs independently predicts mortality in hemodialysis patients, even after adjusting for whole-body phase angle (Chen et al.,Clinical Nutrition, 2024). This suggests that segmental bioelectrical parameters capture local tissue quality not reflected in global metrics.

3.2 Lymphedema and Fluid Redistribution Segmental extracellular water/intracellular water (ECW/ICW) ratios have revolutionized lymphedema monitoring. A 2025 prospective cohort inLymphatic Research and Biologyused segmental BIS to detect breast cancer-related lymphedema an average of 4.2 months earlier than circumferential tape measurement. Critically, the ratio in the affected arm relative to the contralateral arm (L-Dex) now guides prophylactic compression therapy, reducing progression to irreversible stage II lymphedema by 63%.

3.3 Metabolic and Cardiovascular Risk Trunk-to-limb fat ratio (TLFR) derived from segmental DXA has proven superior to waist circumference for predicting visceral adipose tissue (VAT) volume. A 2024 meta-analysis (n=18,432) inDiabetologiafound that TLFR improves reclassification of prediabetic individuals at high metabolic risk by 22% over traditional anthropometry. Moreover, segmental leg fat percentage shows a paradoxical protective effect against cardiovascular mortality—a finding only observable through regional analysis.

4. Challenges and Unresolved Issues

Despite these advances, significant barriers remain. First, reference values for segmental parameters are largely device-specific. The same patient measured on InBody versus seca systems yields trunk lean mass differences of up to 6%, hampering cross-study comparability. Second, trunk segment measurement via BIS is inherently unreliable due to the low impedance of the thoracic cavity—an error that can reach 15% in patients with ascites or pleural effusion. Third, AI models trained on predominantly Caucasian datasets show reduced accuracy in Asian and African populations (mean absolute error increases by 30–40%), raising concerns about health equity.

5. Future Perspectives

The next decade will likely witness three major shifts. First, wearable segmental sensors: flexible, textile-based electrodes integrated into smart garments will enable continuous, ambulatory monitoring of limb fluid shifts during daily activities, chemotherapy infusion, or spaceflight. Preliminary prototypes (e.g., from MIT’s Media Lab) already achieve 95% accuracy compared to clinical BIS for arm segmental volume. Second, multi-omics integration: combining segmental imaging data with circulating biomarkers (e.g., myostatin, IL-6) and gut microbiome profiles could yield mechanistic models of regional muscle wasting. Third, standardized AI reference frameworks: an international consortium (International Society for the Advancement of Kinanthropometry) is developing open-source, harmonized segmental datasets to train universal models, aiming to reduce cross-device variability to <2%.

6. Conclusion Segmental body composition has matured into a precision tool that reveals the body’s regional heterogeneity—information that whole-body metrics systematically discard. With AI-powered fusion of impedance, imaging, and biomechanical data, we are approaching a future where segmental analysis not only diagnoses but predicts and prescribes. The challenge lies not in further technological innovation, but in ensuring equitable, standardized translation to clinical practice worldwide.

References (selected)